Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of ...Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of Red Fuji Apple and contents of individual polyphenols in APE were determined using highperformance liquid chromatography-mass spectrometry（HPLC-MS）.Secondly,forty male National Institude of Health（NIH）mice were randomly divided into 5 groups with 8 animals in each group.The Fenofibrate Capsules（FC）group and APE groups received oral administration of respective drugs for 7 consecutive days.All mice except those in the normal group were intravenously injected through tail vein with Triton WR-1339 on the6th day.Serum and livers from all the mice were obtained 18 h after the injection.The changes in serum total cholesterol（TC）,triglyceride（TG）,lipoprotein lipase（LPL）and hepatic triglyceride lipase（HTGL）were measured by respective kits.Finally,expression of hepatic peroxisome proliferator-activated receptor alpha（PPARα）mRNA was measured by real-time reverse transcription-polymerase chain reaction（RT-PCR）method.Results：Serum TC and TG levels significantly increased in Triton WR-1339-induced model group compared with the normal group（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently reduced the serum level of TG in hyperlipidemic mice（P〈0.01）.Serum LPL and HTGL activities significantly decreased in Triton WR-1339-induced model group compared with the normal group（P〈0.05）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the serum activity of LPL in hyperlipidemic mice（P〈0.05or P〈0.01）.Furthermore,compared with the normal group,hepatic mRNA level of PPARαin the model group significantly decreased（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the expression of PPARαin hyperlipidemic mice（P〈0.05 or P〈0.01）.Conclusion：APE could reduce TG level via up-regulation of LPL activity,which provides new evidence to elucidate the anti-hyperlipidemic effects of APE.展开更多
文摘Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of Red Fuji Apple and contents of individual polyphenols in APE were determined using highperformance liquid chromatography-mass spectrometry（HPLC-MS）.Secondly,forty male National Institude of Health（NIH）mice were randomly divided into 5 groups with 8 animals in each group.The Fenofibrate Capsules（FC）group and APE groups received oral administration of respective drugs for 7 consecutive days.All mice except those in the normal group were intravenously injected through tail vein with Triton WR-1339 on the6th day.Serum and livers from all the mice were obtained 18 h after the injection.The changes in serum total cholesterol（TC）,triglyceride（TG）,lipoprotein lipase（LPL）and hepatic triglyceride lipase（HTGL）were measured by respective kits.Finally,expression of hepatic peroxisome proliferator-activated receptor alpha（PPARα）mRNA was measured by real-time reverse transcription-polymerase chain reaction（RT-PCR）method.Results：Serum TC and TG levels significantly increased in Triton WR-1339-induced model group compared with the normal group（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently reduced the serum level of TG in hyperlipidemic mice（P〈0.01）.Serum LPL and HTGL activities significantly decreased in Triton WR-1339-induced model group compared with the normal group（P〈0.05）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the serum activity of LPL in hyperlipidemic mice（P〈0.05or P〈0.01）.Furthermore,compared with the normal group,hepatic mRNA level of PPARαin the model group significantly decreased（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the expression of PPARαin hyperlipidemic mice（P〈0.05 or P〈0.01）.Conclusion：APE could reduce TG level via up-regulation of LPL activity,which provides new evidence to elucidate the anti-hyperlipidemic effects of APE.
